Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

Type I IFN drives ILC plasticity in radiation-induced lung injury

Preclinical lung irradiation shifted ILC2 cells toward inflammatory ILC1 states, implicating type I interferon signaling in radiation lung injury.

By Dr. Revathy Mohan V.R., MBBS · Nov 1, 2026 · 5 min read

Oncology·NIH

Statins Linked to Earlier Colorectal Cancer Stage in WHI Cohort

In the Women’s Health Initiative, lipophilic statin use was associated with a lower hazard of late-stage colorectal cancer…

Nov 1, 2026

Oncology·Nature

Machine learning predicts persistent fever in cancer patients after antibiotics

Machine learning predicted persistent fever 48–72 hours after antibiotics in hospitalized cancer patients, with external validation and modest…

Nov 1, 2026

Oncology·Lancet ID

CD30+ lymphoproliferative disorders with skin involvement: Lancet review

The Lancet examines biological divergence in CD30+ lymphoproliferative disorders with skin involvement, framing clinical risk and precision approaches.

Nov 1, 2026

Oncology·Nature

DKC1 and PARP inhibition create synthetic lethality in HR-proficient tumors

A study finds DKC1 loss pairs with PARP inhibition to kill homologous recombination-proficient cancer cells by altering chromatin…

Nov 1, 2026

Oncology·ClinicalTrials

PSMA-guided surgery probes tissue-resident T cells in node-positive prostate cancer

TACTIC-P will pair PSMA-guided prostate surgery with deep immune profiling to study tissue-resident T cells in node-positive prostate…

Nov 1, 2026

Oncology·Nature

Proton Therapy Energy Optimization for Hodgkin Lymphoma in Monte Carlo Study

Monte Carlo modeling identified 70 MeV as the best proton energy for a Hodgkin lymphoma target while sparing…

Nov 1, 2026

Oncology·ScienceDaily

Colon Cancer Study Identifies Claudin-4 as BFT Receptor

Johns Hopkins scientists identified claudin-4 as the receptor for a bacterial toxin tied to colorectal cancer and blocked…

Nov 1, 2026

Oncology·BMJ Open

Breast cancer care continuum review protocol targets women’s lived experiences

BMJ Open protocol will synthesize qualitative studies on women’s breast cancer experiences across diagnosis, treatment, survivorship and care…

Nov 1, 2026

Oncology·Front Immunol

Single-cell and spatial transcriptomics reshape iCCA immunotherapy insights

A review of single-cell and spatial transcriptomics in intrahepatic cholangiocarcinoma links immune niches, metabolism, and treatment vulnerability.

Nov 1, 2026

Oncology

Therapeutics, diagnostics and evidence shaping cancer care.

In Brief The 5-minute rounds

New hypertension guideline lowers the treatment threshold to 130/80 mm Hg.
Phase 3 GLP-1 trial reports a 20% cut in major adverse cardiac events.
FDA clears a next-generation CAR-T therapy for relapsed lymphoma.
Meta-analysis links early mobilisation to shorter ICU length of stay.
Rapid guidance broadens empiric antibiotics for suspected sepsis.